Electromyography varies by stage in inclusion body myositis.

electromyography inclusion body myositis motor neuron disease myogenic change neurogenic change number of rimmed vacuoles

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2023
Historique:
received: 16 09 2023
accepted: 14 12 2023
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: epublish

Résumé

Inclusion body myositis (IBM) is a chronic inflammatory muscle disease that is characterized by mixed myogenic and neurogenic electromyography (EMG) findings. We investigated the association between EMG findings and the IBM stage. We included consecutive patients diagnosed with IBM based on muscle biopsy and had needle EMG performed within 1 month of biopsy. Motor unit potential waveform (MUP) in EMG and pathological findings were compared between patients in early and late phases. In total, 30 patients with biopsy-confirmed IBM and 254 muscles were included. The rate of abnormal discharge did not differ according to disease stage. There was a difference in the frequency of occurrence between myogenic suggestive MUP and neurogenic of biceps and flexor digitorum profundus in the late phase. Abnormal MUP was observed even in muscles without muscle weakness, and myogenic changes were predominant in biceps and gastrocnemius with muscle weakness. The biopsy findings on the contralateral side of the muscle where electromyography was performed revealed a tendency for muscles that exhibited myogenic origin to have more inflammatory cells and RV; however, the difference was not significant. The target muscles for EMG must be selected considering the disease stage as well. In the early stages of IBM, EMG results should be interpreted cautiously, as neurogenic suggestive pattern of MUP might also be exhibited. Contralateral electromyography findings may be helpful in selecting muscles for muscle biopsies, such as biceps and quadriceps.

Identifiants

pubmed: 38249752
doi: 10.3389/fneur.2023.1295396
pmc: PMC10797055
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1295396

Informations de copyright

Copyright © 2024 Mano, Iguchi, Eura, Iwasa, Yamada, Horikawa and Sugie.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Tomoo Mano (T)

Department of Neurology, Nara Medical University, Kashihara, Japan.
Department of Rehabilitation Medicine, Nara Prefecture General Medical Center, Nara, Japan.

Naohiko Iguchi (N)

Department of Neurology, Nara Medical University, Kashihara, Japan.

Nobuyuki Eura (N)

Department of Neurology, Nara Medical University, Kashihara, Japan.

Naoki Iwasa (N)

Department of Neurology, Nara Medical University, Kashihara, Japan.

Nanami Yamada (N)

Department of Neurology, Nara Medical University, Kashihara, Japan.

Hirosei Horikawa (H)

Department of Neurology, Nara Medical University, Kashihara, Japan.

Kazuma Sugie (K)

Department of Neurology, Nara Medical University, Kashihara, Japan.

Classifications MeSH